From Vaccine to Drug Making, AstraZeneca is Relying on AI for Growth

Ever since the outbreak of coronavirus, the news is filled with daily record-breaking cases, deaths, and fortunately, vaccine-related improvements. When Pfizer became the first company among the democratic countries to unravel a vaccine, the stock market prices skyrocketed. Soon, Moderna, AstraZeneca, and Johnson and Johnson followed suit. AstraZeneca, one of the biggest contributors of the Covid-19 vaccine is using artificial intelligence to not just power Covishield vaccine, but also in other drug discoveries. AstraZeneca is a global, science-led biopharmaceutical business. The company produces major innovative medicines that are being used by millions of patients worldwide.